Pfizer Canada has tripled the size of an innovation fund designed to advance commercialization of promising compounds emanating from the Centre for Drug Research and Development (CDRD) in British Columbia. Pfizer added $2 million to the $1 million it contributed one year ago. The Pfizer-CDRD Innovation Fund already supports six projects in the areas of cancer and diabetic ulcer healing....